Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001214659-25-012492·1Globe Capital LLC
Schedule 13G ownership disclosure
CRESCENT BIOPHARMA INC.
Ordinary Shares, par value $0.001 per share · CUSIP: 38000Q201
Event date: 2025-08-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- 1Globe Capital LLC
Shares: 896,712.00 · Class: 6.45%
- Jiaqiang Li
Shares: 896,712.00 · Class: 6.45%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-012492
- Form type
- SCHEDULE 13G
- Filer
- 1Globe Capital LLC
- CIK
- CIK 1562189
- Filed
- Aug 20, 2025
- Reporting period
- Aug 13, 2025
- Description
- Schedule 13G beneficial ownership